169 related articles for article (PubMed ID: 32718384)
1. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.
Lee HJ; Han HJ; Lee JY; Son WC
Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384
[TBL] [Abstract][Full Text] [Related]
2. Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components.
Amini P; Nassiri S; Malbon A; Markkanen E
Sci Rep; 2020 Mar; 10(1):5506. PubMed ID: 32218455
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study.
Terzaghi L; Banco B; Groppetti D; Dall'Acqua PC; Giudice C; Pecile A; Grieco V; Lodde V; Luciano AM
Res Vet Sci; 2020 Oct; 132():101-107. PubMed ID: 32544632
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
[TBL] [Abstract][Full Text] [Related]
5. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
[TBL] [Abstract][Full Text] [Related]
7. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
8. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
9. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.
Michel E; Feldmann SK; Kowalewski MP; Bley CR; Boos A; Guscetti F; Reichler IM
BMC Vet Res; 2012 May; 8():72. PubMed ID: 22647582
[TBL] [Abstract][Full Text] [Related]
10. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
11. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
12. Co-localization of PTEN and E-cadherin in canine mammary hyperplasias and benign and malignant mammary tumors.
Asproni P; Ressel L; Millanta F; Vannozzi I; Poli A
Res Vet Sci; 2015 Dec; 103():113-8. PubMed ID: 26679805
[TBL] [Abstract][Full Text] [Related]
13. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
[TBL] [Abstract][Full Text] [Related]
14. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-inducible factor-1α and vascular density in mammary adenomas and adenocarcinomas in bitches.
Madej JA; Madej JP; Dziegiel P; Pula B; Nowak M
Acta Vet Scand; 2013 Oct; 55(1):73. PubMed ID: 24153191
[TBL] [Abstract][Full Text] [Related]
17. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
18. The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors.
Yoshida K; Yoshida S; Choisunirachon N; Saito T; Matsumoto K; Saeki K; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
J Vet Med Sci; 2014 Oct; 76(10):1321-7. PubMed ID: 24931646
[TBL] [Abstract][Full Text] [Related]
19. Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.
Sakai K; Yonezawa T; Yamawaki H; Oyamada T
J Vet Med Sci; 2015 Oct; 77(10):1319-22. PubMed ID: 25985817
[TBL] [Abstract][Full Text] [Related]
20. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.
Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S
Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
